Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brain SPECT imaging and psychiatry.

R L Van Heertum1

  • 1Department of Nuclear Medicine, Columbia Presbyterian Medical Center, New York, N.Y.

The Journal of Clinical Psychiatry
|November 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single photon emission CT and positron emission tomography in the evaluation of neurologic disease.

Radiologic clinics of North America·2001
Same author

The role of nuclear medicine in the evaluation of pancreatic disease.

The Surgical clinics of North America·2001
Same author

Regional cerebral blood flow in mood disorders, V.: Effects of antidepressant medication in late-life depression.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2000
Same author

Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.

Biological psychiatry·2000
Same author

In vivo quantification of brain serotonin transporters in humans using [11C]McN 5652.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2000
Same author

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.

Proceedings of the National Academy of Sciences of the United States of America·2000
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles

Recent advances in neuro-single photon emission computerized tomography (SPECT) offer new tools for evaluating psychiatric disorders. This presentation covers improved instrumentation and radiopharmaceuticals for psychiatric patient assessment.

Area of Science:

  • Neuroimaging
  • Psychiatric Research
  • Medical Technology

Background:

  • Neuroimaging plays a crucial role in understanding brain function.
  • Single photon emission computerized tomography (SPECT) is an established neuroimaging technique.
  • Evaluating psychiatric disorders requires advanced diagnostic tools.

Purpose of the Study:

  • To outline the utility of neuroSPECT in psychiatric disorder evaluation.
  • To discuss recent technological advancements in cerebral SPECT.
  • To explore the impact of new radiopharmaceuticals on psychiatric assessment.

Main Methods:

  • Review of recent developments in neuroSPECT instrumentation.
  • Analysis of novel radiopharmaceuticals for brain imaging.
  • Discussion of clinical applications in psychiatry.

Related Experiment Videos

Main Results:

  • Emerging technologies enhance the diagnostic capabilities of neuroSPECT.
  • New radiopharmaceuticals offer improved visualization of neurobiological targets.
  • Advancements facilitate more precise evaluation of psychiatric conditions.

Conclusions:

  • NeuroSPECT is evolving as a valuable tool for psychiatric diagnosis.
  • Technological progress in SPECT instrumentation and radiopharmaceuticals is key.
  • These developments hold significant promise for psychiatric patient care.